Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Population pharmacokinetics II: estimation methods.

Ene I Ette1, Paul J Williams

  • 1Vertex Pharmaceuticals, Inc., Cambridge, MA, USA. Ene_Ette@vpharm.com

The Annals of Pharmacotherapy
|September 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential Impact of Pharmacokinetic and Pharmacodynamic Variability on Response to Combination Therapy.

Pharmacology research & perspectives·2026
Same author

Confirming the Suitability of a Gentamicin Dosing Strategy in Neonates Using the Population Pharmacokinetic Approach with Truncated Sampling Duration.

Children (Basel, Switzerland)·2024
Same author

Predictors of gentamicin therapy failure in neonates with sepsis.

Pharmacology research & perspectives·2024
Same author

Differentiation of Listeria monocytogenes serotypes using near infrared hyperspectral imaging.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2024
Same author

Exploring the potential of hyperspectral imaging for microbial assessment of meat: A review.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2024
Same author

A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro.

In silico pharmacology·2023

Population pharmacokinetic (PPK) estimation methods were compared. Nonlinear mixed-effects modeling yields less biased PPK parameter estimates than naive or two-stage approaches.

Area of Science:

  • Pharmacokinetics
  • Pharmacometrics
  • Statistical modeling

Background:

  • Population pharmacokinetic (PPK) models are crucial for understanding drug behavior in diverse patient populations.
  • Various methods exist for estimating PPK models, each with distinct mathematical and statistical underpinnings.
  • Accurate PPK estimation is vital for optimizing drug dosage and therapeutic outcomes.

Purpose of the Study:

  • To comprehensively review and compare different population pharmacokinetic (PPK) model estimation approaches.
  • To analyze the mathematical foundations, statistical properties, software implementations, and assumptions of various PPK estimation methods.
  • To provide a comparative overview of PPK estimation techniques for researchers and practitioners.

Main Methods:

Related Experiment Videos

  • A systematic literature search of MEDLINE (1977-2004) and review articles was conducted.
  • Information on PPK estimation methods was synthesized with expert experience.
  • Sixty-four relevant articles were selected and analyzed for their methodological contributions.

    • Main Results:

    • A spectrum of PPK estimation methods was reviewed, including naive averaging, naive pooled, standard two-stage, and nonlinear mixed-effects modeling.
    • Advantages and limitations of each estimation approach were detailed.
    • Nonlinear mixed-effects modeling approaches were highlighted for their advanced statistical properties.

    Conclusions:

    • Nonlinear mixed-effects modeling (NMEM) provides less biased population pharmacokinetic (PPK) parameter estimates compared to naive and standard two-stage methods.
    • NMEM approaches effectively characterize both fixed and random effects in population pharmacokinetic (PPK) models.
    • NONMEM is identified as the predominant software for implementing population pharmacokinetic (PPK) analyses.